Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company also has Varian Particle Therapy (VPT) and the operations of the Ginzton Technology Center (GTC). Its VPT business develops, designs, manufactures, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams for the treatment of cancer. Its ProBeam system is capable of delivering intensity modulated proton therapy (IMPT) using pencil beam scanning technology. Its ProBeam Compact is a single room proton therapy product.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Advanced Medical Equipment & Technology
- Sub-Industry: Health Care Equipment
- Symbol: NYSE:VAR
- CUSIP: 92220P10
- Web: www.varian.com
Capitalization:- Market Cap: $9.80801 billion
- Outstanding Shares: 91,800,000
Average Prices:- 50 Day Moving Avg: $102.10
- 200 Day Moving Avg: $97.84
- 52 Week Range: $75.20 - $107.87
P/E:- Trailing P/E Ratio: 35.21
- Foreward P/E Ratio: 24.24
- P/E Growth: 2.75
Sales & Book Value:- Annual Revenue: $3.27 billion
- Price / Sales: 2.98
- Book Value: $15.16 per share
- Price / Book: 7.00
Profitability:- EBIDTA: $643 million
- Net Margins: 9.50%
- Return on Equity: 24.70%
- Return on Assets: 11.12%
Debt:- Debt-to-Equity Ratio: 0.18%
- Current Ratio: 1.62%
- Quick Ratio: 1.26%
Misc:- Average Volume: 775,094 shs.
- Beta: 0.58
- Short Ratio: 7.65
Frequently Asked Questions for Varian Medical Systems (NYSE:VAR)
What is Varian Medical Systems' stock symbol?
Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."
How were Varian Medical Systems' earnings last quarter?
Varian Medical Systems, Inc. (NYSE:VAR) issued its quarterly earnings data on Wednesday, July, 26th. The company reported $1.04 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.95 by $0.09. The business earned $662.40 million during the quarter, compared to analysts' expectations of $663.86 million. Varian Medical Systems had a net margin of 9.50% and a return on equity of 24.70%. Varian Medical Systems's revenue for the quarter was up 3.0% on a year-over-year basis. During the same period in the previous year, the company earned $1.00 earnings per share. View Varian Medical Systems' Earnings History.
When will Varian Medical Systems make its next earnings announcement?
What guidance has Varian Medical Systems issued on next quarter's earnings?
Varian Medical Systems issued an update on its fourth quarter earnings guidance on Wednesday, July, 26th. The company provided earnings per share guidance of $1.15-$1.23 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.18.
Where is Varian Medical Systems' stock going? Where will Varian Medical Systems' stock price be in 2017?
10 equities research analysts have issued 12-month price targets for Varian Medical Systems' shares. Their predictions range from $81.50 to $106.00. On average, they expect Varian Medical Systems' stock price to reach $94.94 in the next year. View Analyst Ratings for Varian Medical Systems.
What are analysts saying about Varian Medical Systems stock?
Here are some recent quotes from research analysts about Varian Medical Systems stock:
- 1. According to Zacks Investment Research, "Varian Medical's oncology and Proton therapy business growth prospects remain impressive. The company is addressing both the tier 1 and mid-tier markets through its Edge, Truebeam and VitalBeam, Halcyon products. Varian has been winning contracts, not only in the Americas but also in the emerging international markets, which is a huge positive. We believe China and Africa present significant top-line growth opportunity in the near term. The company is opening up new offices in Africa and the Middle East, which shows that it is aware of the growth opportunities in the region. Varian Medical posted an impressive second quarter of fiscal 2017, beating the Zacks Consensus Estimate on both the counts. The company’s upbeat guidance for the coming quarters is a positive. Share price movement in the past three months has been encouraging, trading above the broader industry." (7/13/2017)
- 2. Jefferies Group LLC analysts commented, "We hosted VAR CEO and CFO for a lunch. Key takeaways: 1) VREX spin process was all inclusive; 2) F17 RemainCo outlook calls for HSD EPS growth; 3) RadOnc outlook stable on multiple fronts near and long-term; 3) next-gen linac expected in 2H17; 5) aim is to double Software in 5-years; 6) proton stable postCTCL with glimmers of light in tunnel; and 7) at least $1.0bn in debt capacity for M&A. We are publishing revised stand-alone estimates and PT of $88." (2/8/2017)
Who are some of Varian Medical Systems' key competitors?
Some companies that are related to Varian Medical Systems include Waters Corporation (WAT), ResMed (RMD), Hologic (HOLX), PerkinElmer (PKI), ABIOMED (ABMD), Bruker Corporation (BRKR), Alere (ALR), Quidel Corporation (QDEL), Accelerate Diagnostics (AXDX), Natus Medical Incorporated (BABY), Mazor Robotics (MZOR), ABAXIS (ABAX), Luminex Corporation (LMNX), LeMaitre Vascular (LMAT), Pacific Biosciences of California (PACB), GenMark Diagnostics (GNMK), Accuray Incorporated (ARAY) and ViewRay (VRAY).
Who are Varian Medical Systems' key executives?
Varian Medical Systems' management team includes the folowing people:
- R. Andrew Eckert, Independent Chairman of the Board
- Dow R. Wilson, President, Chief Executive Officer
- Timothy E. Guertin, Vice Chairman of the Board
- Elisha W. Finney, Chief Financial Officer, Executive Vice President - Finance
- Gary E. Bischoping Jr., Chief Financial Officer
- Kolleen T. Kennedy, Executive Vice President and President - Oncology Systems
- John W. Kuo, Senior Vice President, General Counsel, Corporate Secretary
- Rafael Torres, Senior Vice President - Business Development and Strategy
- Jose Baselga M.D., Ph.D., Director
- Jean-Luc Butel, Director
Who owns Varian Medical Systems stock?
Varian Medical Systems' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (9.99%), BlackRock Inc. (9.19%), First Eagle Investment Management LLC (5.10%), State Street Corp (4.60%), Janus Henderson Group PLC (4.09%) and Alecta Pensionsforsakring Omsesidigt (3.09%). Company insiders that own Varian Medical Systems stock include Clarence R Verhoef, Dow R Wilson, Elisha W Finney, John W Kuo, Kolleen T Kennedy, Mark R Laret, R Andrew Eckert, Ruediger Naumann-Etienne, Susan L Bostrom and Timothy E Guertin. View Institutional Ownership Trends for Varian Medical Systems.
Who sold Varian Medical Systems stock? Who is selling Varian Medical Systems stock?
Varian Medical Systems' stock was sold by a variety of institutional investors in the last quarter, including Fairpointe Capital LLC, Anchor Capital Advisors LLC, New York State Common Retirement Fund, Atlanta Capital Management Co. L L C, Swiss National Bank, First Trust Advisors LP, Quantitative Investment Management LLC and Van ECK Associates Corp. Company insiders that have sold Varian Medical Systems stock in the last year include Dow R Wilson, Elisha W Finney, John W Kuo, Kolleen T Kennedy, Mark R Laret, Susan L Bostrom and Timothy E Guertin. View Insider Buying and Selling for Varian Medical Systems.
Who bought Varian Medical Systems stock? Who is buying Varian Medical Systems stock?
Varian Medical Systems' stock was bought by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Koch Industries Inc., Arrowstreet Capital Limited Partnership, York Capital Management Global Advisors LLC, BlackRock Inc., Parametric Portfolio Associates LLC, Gotham Asset Management LLC and FMR LLC. View Insider Buying and Selling for Varian Medical Systems.
How do I buy Varian Medical Systems stock?
Shares of Varian Medical Systems can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Varian Medical Systems' stock price today?
One share of Varian Medical Systems stock can currently be purchased for approximately $106.18.
MarketBeat Community Rating for Varian Medical Systems (NYSE VAR)MarketBeat's community ratings are surveys of what our community members think about Varian Medical Systems and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Varian Medical Systems (NYSE:VAR) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 2 Sell Ratings, 6 Hold Ratings, 2 Buy Ratings |
| Consensus Rating: | Hold (Score: 2.00) |
| Consensus Price Target: | $94.94 (10.59% downside) |
Analysts' Ratings History for Varian Medical Systems (NYSE:VAR)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 9/7/2017 | BTIG Research | Downgrade | Buy -> Neutral | | Medium |  |
| 9/1/2017 | Royal Bank Of Canada | Reiterated Rating | Hold | $100.00 | N/A | |
| 8/28/2017 | Robert W. Baird | Reiterated Rating | Hold | $99.00 | Low | |
| 5/17/2017 | Aegis | Reiterated Rating | Hold | $91.00 | Low | |
| 5/16/2017 | Goldman Sachs Group, Inc. (The) | Initiated Coverage | Neutral -> Neutral | $92.00 | Low | |
| 5/15/2017 | Citigroup Inc. | Upgrade | Neutral -> Buy | | Low | |
| 5/11/2017 | Jefferies Group LLC | Reiterated Rating | Buy | | Low | |
| 4/27/2017 | Barrington Research | Downgrade | Outperform -> Market Perform | | High | |
| 4/24/2017 | Off Wall Street | Initiated Coverage | Sell | | Low | |
| 1/26/2017 | Evercore ISI | Downgrade | Hold -> Sell | $81.50 | N/A | |
| 7/28/2016 | Morgan Stanley | Boost Price Target | Underweight | $80.00 -> $86.00 | N/A | |
| 7/28/2016 | Brean Capital | Boost Price Target | Buy | $87.00 -> $90.00 | N/A | |
| 10/20/2015 | J P Morgan Chase & Co | Reiterated Rating | Neutral | $95.00 -> $75.00 | N/A | |
(Data available from 9/20/2015 forward)
Earnings History for Varian Medical Systems (NYSE:VAR)Earnings History by Quarter for Varian Medical Systems (NYSE VAR)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/24/2017 | | $1.19 | | | | | N/A | |
| 7/26/2017 | Q3 2017 | $0.95 | $1.04 | $663.86 million | $662.40 million | View | N/A | |
| 4/26/2017 | Q2 2017 | $0.88 | $0.89 | $639.26 million | $655.00 million | View | N/A | |
| 10/26/2016 | Q4112 | $1.34 | $1.38 | $880.29 million | $912.00 million | View | Listen | |
| 7/27/2016 | Q316 | $1.17 | $1.22 | $779.90 million | $789.40 million | View | Listen | |
| 4/27/2016 | Q216 | $1.08 | $1.09 | $769.56 million | $758.80 million | View | Listen | |
| 1/27/2016 | Q116 | $0.94 | $0.99 | $748.01 million | $757.00 million | View | Listen | |
| 10/28/2015 | Q4 | $1.10 | $1.04 | $813.18 million | $817.80 million | View | Listen | |
| 7/29/2015 | Q3 | $1.10 | $1.13 | $810.41 million | $784.00 million | View | Listen | |
| 4/29/2015 | Q215 | $1.00 | $1.05 | $799.66 million | $759.40 million | View | N/A | |
| 1/28/2015 | Q115 | $0.87 | $0.99 | $720.83 million | $737.90 million | View | N/A | |
| 10/22/2014 | Q415 | $1.21 | $1.02 | $837.86 million | $812.10 million | View | Listen | |
| 7/23/2014 | Q314 | $1.09 | $1.08 | $767.52 million | $747.70 million | View | N/A | |
| 4/23/2014 | Q4112 | $1.03 | $1.04 | $772.84 million | $779.00 million | View | N/A | |
| 1/22/2014 | Q3112 | $0.90 | $0.91 | $718.23 million | $712.00 million | View | N/A | |
| 10/23/2013 | Q3112 | $1.12 | $1.08 | $779.02 million | $770.00 million | View | N/A | |
| 7/24/2013 | Q3 2013 | $1.01 | $1.03 | $749.01 million | $726.20 million | View | N/A | |
| 4/24/2013 | Q2 2013 | $1.02 | $1.04 | $758.02 million | $768.40 million | View | N/A | |
| 1/23/2013 | Q1 2013 | $0.87 | $0.86 | $676.15 million | $678.40 million | View | N/A | |
| 10/25/2012 | | $1.03 | $1.08 | | | View | N/A | |
| 7/25/2012 | | $0.94 | $0.96 | | | View | N/A | |
| 4/25/2012 | | $0.96 | $0.96 | | | View | N/A | |
| 1/25/2012 | | $0.75 | $0.79 | | | View | N/A | |
| 10/27/2011 | | $0.97 | $0.95 | | | View | N/A | |
| 7/27/2011 | | $0.83 | $0.83 | | | View | N/A | |
| 4/27/2011 | | $0.85 | $0.86 | | | View | N/A | |
| 1/26/2011 | | $0.73 | $0.80 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Varian Medical Systems (NYSE:VAR)2017 EPS Consensus Estimate: $4.18
2018 EPS Consensus Estimate: $4.43
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 2 | $1.04 | $1.06 | $1.05 |
| Q2 2017 | 2 | $0.91 | $1.08 | $1.00 |
| Q3 2017 | 2 | $0.94 | $0.95 | $0.95 |
| Q4 2017 | 2 | $1.17 | $1.20 | $1.19 |
| Q1 2018 | 2 | $0.93 | $1.07 | $1.00 |
| Q2 2018 | 2 | $1.02 | $1.03 | $1.03 |
| Q3 2018 | 2 | $1.07 | $1.14 | $1.11 |
| Q4 2018 | 2 | $1.26 | $1.33 | $1.30 |
(Data provided by Zacks Investment Research)
Dividend History for Varian Medical Systems (NYSE:VAR)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Varian Medical Systems (NYSE:VAR)Insider Ownership Percentage: 0.91%
Institutional Ownership Percentage: 99.28%
Insider Trades by Quarter for Varian Medical Systems (NYSE:VAR)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 9/13/2017 | Kolleen T Kennedy | EVP | Sell | 933 | $107.29 | $100,101.57 | |
| 9/12/2017 | Kolleen T Kennedy | EVP | Sell | 1,088 | $107.33 | $116,775.04 | |
| 9/7/2017 | Dow R Wilson | Insider | Sell | 15,059 | $105.41 | $1,587,369.19 | |
| 8/31/2017 | Kolleen T Kennedy | EVP | Sell | 931 | $105.00 | $97,755.00 | |
| 8/14/2017 | Kolleen T Kennedy | EVP | Sell | 1,088 | $97.91 | $106,526.08 | |
| 8/7/2017 | Dow R Wilson | Insider | Sell | 15,059 | $96.48 | $1,452,892.32 | |
| 7/13/2017 | John W Kuo | SVP | Sell | 1,597 | $104.43 | $166,774.71 | |
| 7/13/2017 | Kolleen T Kennedy | EVP | Sell | 2,021 | $104.73 | $211,659.33 | |
| 7/12/2017 | John W Kuo | SVP | Sell | 863 | $104.48 | $90,166.24 | |
| 7/12/2017 | Kolleen T Kennedy | EVP | Sell | 1,088 | $104.49 | $113,685.12 | |
| 7/10/2017 | Dow R Wilson | Insider | Sell | 15,060 | $103.37 | $1,556,752.20 | |
| 6/20/2017 | Kolleen T Kennedy | EVP | Sell | 26,092 | $105.00 | $2,739,660.00 | |
| 6/13/2017 | John W Kuo | SVP | Sell | 734 | $101.91 | $74,801.94 | |
| 6/12/2017 | John W Kuo | SVP | Sell | 863 | $101.25 | $87,378.75 | |
| 6/12/2017 | Kolleen T Kennedy | EVP | Sell | 1,087 | $101.20 | $110,004.40 | |
| 6/9/2017 | Timothy E Guertin | Director | Sell | 16,000 | $103.22 | $1,651,520.00 | |
| 6/8/2017 | Mark R Laret | Director | Sell | 1,428 | $103.47 | $147,755.16 | |
| 6/1/2017 | Kolleen T Kennedy | EVP | Sell | 56,573 | $99.76 | $5,643,722.48 | |
| 5/31/2017 | John W Kuo | SVP | Sell | 19,819 | $99.67 | $1,975,359.73 | |
| 5/12/2017 | John W Kuo | SVP | Sell | 862 | $96.39 | $83,088.18 | |
| 5/2/2017 | Susan L Bostrom | Director | Sell | 3,589 | $91.08 | $326,886.12 | |
| 4/12/2017 | John W Kuo | SVP | Sell | 864 | $89.74 | $77,535.36 | |
| 3/17/2017 | John W Kuo | SVP | Sell | 3,876 | $91.75 | $355,623.00 | |
| 3/13/2017 | John W Kuo | SVP | Sell | 862 | $87.89 | $75,761.18 | |
| 3/1/2017 | John W Kuo | SVP | Sell | 10,353 | $84.81 | $878,037.93 | |
| 1/5/2017 | Dow R Wilson | Insider | Sell | 13,334 | $88.74 | $1,183,259.16 | |
| 12/8/2016 | John W Kuo | SVP | Sell | 1,267 | $90.33 | $114,448.11 | |
| 12/5/2016 | Dow R Wilson | Insider | Sell | 10,000 | $90.03 | $900,300.00 | |
| 11/7/2016 | Dow R Wilson | Insider | Sell | 10,000 | $90.59 | $905,900.00 | |
| 10/31/2016 | Timothy E Guertin | Director | Sell | 4,000 | $90.32 | $361,280.00 | |
| 10/20/2016 | John W Kuo | SVP | Sell | 21,266 | $103.70 | $2,205,284.20 | |
| 10/5/2016 | Dow R Wilson | Insider | Sell | 10,000 | $99.44 | $994,400.00 | |
| 10/3/2016 | Elisha W Finney | CFO | Sell | 4,668 | $98.87 | $461,525.16 | |
| 9/15/2016 | John W Kuo | SVP | Sell | 4,073 | $95.47 | $388,849.31 | |
| 9/7/2016 | Elisha W Finney | CFO | Sell | 9,000 | $96.95 | $872,550.00 | |
| 9/6/2016 | Dow R Wilson | Insider | Sell | 10,000 | $96.08 | $960,800.00 | |
| 9/1/2016 | Elisha W Finney | CFO | Sell | 2,000 | $95.82 | $191,640.00 | |
| 8/5/2016 | Dow R Wilson | Insider | Sell | 10,000 | $95.14 | $951,400.00 | |
| 8/1/2016 | Clarence R Verhoef | SVP | Sell | 9,483 | $94.88 | $899,747.04 | |
| 8/1/2016 | Elisha W Finney | CFO | Sell | 25,334 | $94.90 | $2,404,196.60 | |
| 8/1/2016 | Timothy E. Guertin | Director | Sell | 4,000 | $94.88 | $379,520.00 | |
| 7/5/2016 | Dow R Wilson | CEO | Sell | 10,000 | $82.08 | $820,800.00 | |
| 6/27/2016 | Dow R Wilson | CEO | Sell | 10,000 | $78.27 | $782,700.00 | |
| 6/8/2016 | Ruediger Naumann-Etienne | Director | Sell | 1,000 | $84.83 | $84,830.00 | |
| 6/3/2016 | Mark R Laret | Director | Sell | 1,545 | $83.48 | $128,976.60 | |
| 5/2/2016 | Timothy E. Guertin | Director | Sell | 4,000 | $81.55 | $326,200.00 | |
| 4/20/2016 | Elisha W Finney | CFO | Sell | 4,000 | $85.95 | $343,800.00 | |
| 4/18/2016 | Clarence R Verhoef | SVP | Sell | 2,500 | $85.00 | $212,500.00 | |
| 3/23/2016 | Dow R Wilson | CEO | Sell | 45,650 | $78.86 | $3,599,959.00 | |
| 3/10/2016 | Ruediger Naumann-Etienne | Director | Sell | 428 | $77.99 | $33,379.72 | |
| 3/7/2016 | Timothy E. Guertin | Director | Sell | 4,000 | $79.47 | $317,880.00 | |
| 2/17/2016 | Elisha W. Finney | CFO | Sell | 2,454 | $78.59 | $192,859.86 | |
| 12/7/2015 | Dow R. Wilson | CEO | Sell | 9,000 | $80.00 | $720,000.00 | |
| 12/2/2015 | R Andrew Eckert | Director | Sell | 3,000 | $81.67 | $245,010.00 | |
| 11/24/2015 | Elisha W. Finney | CFO | Sell | 2,334 | $80.90 | $188,820.60 | |
| 11/6/2015 | Dow R. Wilson | CEO | Sell | 18,000 | $80.26 | $1,444,680.00 | |
| 9/8/2015 | Dow R. Wilson | CEO | Sell | 9,000 | $80.05 | $720,450.00 | |
| 7/6/2015 | Dow R Wilson | CEO | Sell | 9,000 | $85.80 | $772,200.00 | |
| 7/2/2015 | Elisha W Finney | CFO | Sell | 2,000 | $85.95 | $171,900.00 | |
| 7/1/2015 | Timothy E Guertin | Director | Sell | 25,000 | $84.20 | $2,105,000.00 | |
| 6/5/2015 | Dow R Wilson | CEO | Sell | 9,000 | $86.29 | $776,610.00 | |
| 6/1/2015 | Elisha W Finney | CFO | Sell | 2,000 | $85.99 | $171,980.00 | |
| 6/1/2015 | Timothy E Guertin | Director | Sell | 25,000 | $86.08 | $2,152,000.00 | |
| 5/6/2015 | Dow R Wilson | CEO | Sell | 9,000 | $86.64 | $779,760.00 | |
| 4/17/2015 | Dow R Wilson | CEO | Sell | 18,760 | $93.63 | $1,756,498.80 | |
| 4/1/2015 | Elisha W Finney | CFO | Sell | 5,000 | $92.76 | $463,800.00 | |
| 4/1/2015 | Timothy E Guertin | Director | Sell | 25,000 | $92.76 | $2,319,000.00 | |
| 3/20/2015 | Dow R Wilson | CEO | Sell | 18,759 | $94.44 | $1,771,599.96 | |
| 3/16/2015 | Kolleen T Kennedy | EVP | Sell | 1,972 | $95.00 | $187,340.00 | |
| 3/6/2015 | Timothy E Guertin | Director | Sell | 4,000 | $93.50 | $374,000.00 | |
| 3/2/2015 | Elisha W Finney | CFO | Sell | 5,000 | $93.44 | $467,200.00 | |
| 3/2/2015 | Timothy E Guertin | Director | Sell | 50,000 | $93.48 | $4,674,000.00 | |
| 2/23/2015 | Elisha W Finney | CFO | Sell | 1,326 | $92.97 | $123,278.22 | |
| 2/10/2015 | Mark R Laret | Director | Sell | 10,000 | $92.32 | $923,200.00 | |
| 2/3/2015 | Venkatraman Thyagarajan | Director | Sell | 10,000 | $92.71 | $927,100.00 | |
| 2/2/2015 | Dow R Wilson | CEO | Sell | 60,000 | $91.78 | $5,506,800.00 | |
| 2/2/2015 | Elisha W Finney | CFO | Sell | 6,667 | $91.79 | $611,963.93 | |
| 2/2/2015 | John W Kuo | SVP | Sell | 3,490 | $92.04 | $321,219.60 | |
| 2/2/2015 | Ruediger Naumann-Etienne | Director | Sell | 10,000 | $91.87 | $918,700.00 | |
| 1/5/2015 | Timothy E Guertin | Director | Sell | 50,000 | $86.27 | $4,313,500.00 | |
| 1/2/2015 | Elisha W Finney | CFO | Sell | 15,000 | $87.05 | $1,305,750.00 | |
| 12/11/2014 | Timothy E Guertin | Director | Sell | 105,000 | $86.67 | $9,100,350.00 | |
| 12/1/2014 | Elisha W Finney | CFO | Sell | 21,000 | $88.72 | $1,863,120.00 | |
| 11/24/2014 | Elisha W Finney | CFO | Sell | 2,930 | $88.24 | $258,543.20 | |
| 11/17/2014 | Elisha W Finney | CFO | Sell | 1,837 | $87.71 | $161,123.27 | |
| 11/11/2014 | Kolleen T Kennedy | SVP | Sell | 1,242 | $85.79 | $106,551.18 | |
| 11/10/2014 | Ruediger Naumann-Etienne | Director | Sell | 5,000 | $85.31 | $426,550.00 | |
| 11/3/2014 | Elisha W Finney | CFO | Sell | 25,000 | $83.82 | $2,095,500.00 | |
| 11/3/2014 | Timothy E Guertin | Director | Sell | 80,000 | $83.72 | $6,697,600.00 | |
| 10/29/2014 | Elisha W Finney | CFO | Sell | 10,000 | $83.95 | $839,500.00 | |
| 10/27/2014 | Kolleen T Kennedy | SVP | Sell | 1,240 | $81.00 | $100,440.00 | |
| 10/1/2014 | Elisha W Finney | CFO | Sell | 15,000 | $79.98 | $1,199,700.00 | |
| 9/11/2014 | John W Kuo | SVP | Sell | 605 | $85.82 | $51,921.10 | |
| 9/2/2014 | Elisha W Finney | CFO | Sell | 20,000 | $85.18 | $1,703,600.00 | |
| 8/20/2014 | Venkatraman Thyagarajan | Director | Sell | 5,000 | $84.25 | $421,250.00 | |
| 8/7/2014 | Elisha W Finney | CFO | Sell | 5,000 | $83.95 | $419,750.00 | |
| 8/1/2014 | Elisha W Finney | CFO | Sell | 15,000 | $81.66 | $1,224,900.00 | |
| 8/1/2014 | Timothy E Guertin | Director | Sell | 80,000 | $81.69 | $6,535,200.00 | |
| 7/9/2014 | John W Kuo | SVP | Sell | 582 | $85.00 | $49,470.00 | |
| 7/1/2014 | Elisha W Finney | CFO | Sell | 20,000 | $83.86 | $1,677,200.00 | |
| 6/23/2014 | John W Kuo | SVP | Sell | 1,745 | $85.00 | $148,325.00 | |
| 6/16/2014 | Kolleen T Kennedy | SVP | Sell | 1,416 | $82.42 | $116,706.72 | |
| 6/2/2014 | Elisha W Finney | CFO | Sell | 10,000 | $82.35 | $823,500.00 | |
| 5/12/2014 | Kolleen Kennedy | SVP | Sell | 1,417 | $81.96 | $116,137.32 | |
| 5/1/2014 | Elisha Finney | CFO | Sell | 10,000 | $78.99 | $789,900.00 | |
| 5/1/2014 | Timothy Guertin | Director | Sell | 80,000 | $78.98 | $6,318,400.00 | |
| 4/11/2014 | Kolleen T Kennedy | SVP | Sell | 640 | $72.15 | $46,176.00 | |
| 4/1/2014 | Elisha Finney | CFO | Sell | 10,000 | $83.97 | $839,700.00 | |
| 3/17/2014 | Clarence Verhoef | SVP | Sell | 1,140 | $84.70 | $96,558.00 | |
| 3/11/2014 | Kolleen Kennedy | SVP | Sell | 1,417 | $84.39 | $119,580.63 | |
| 3/10/2014 | Timothy Guertin | Director | Sell | 80,000 | $84.05 | $6,724,000.00 | |
| 3/3/2014 | Elisha Finney | CFO | Sell | 10,000 | $83.41 | $834,100.00 | |
| 2/21/2014 | Mark Laret | Director | Sell | 1,411 | $84.06 | $118,608.66 | |
| 2/11/2014 | Kolleen Kennedy | SVP | Sell | 1,416 | $80.59 | $114,115.44 | |
| 2/10/2014 | R Andrew Eckert | Director | Sell | 5,887 | $80.52 | $474,021.24 | |
| 2/3/2014 | Elisha Finney | CFO | Sell | 10,000 | $79.34 | $793,400.00 | |
| 2/3/2014 | Timothy Guertin | Director | Sell | 27,000 | $79.34 | $2,142,180.00 | |
| 1/31/2014 | Susan Bostrom | Director | Sell | 18,900 | $81.50 | $1,540,350.00 | |
| 1/2/2014 | Elisha Finney | CFO | Sell | 24,321 | $77.69 | $1,889,498.49 | |
| 1/2/2014 | Richard Levy | Director | Sell | 20,000 | $77.68 | $1,553,600.00 | |
| 12/30/2013 | John Kuo | SVP | Sell | 3,027 | $77.08 | $233,321.16 | |
| 12/23/2013 | Clarence Verhoef | SVP | Sell | 1,297 | $76.13 | $98,740.61 | |
| 12/9/2013 | Dow Wilson | CEO | Sell | 95,000 | $79.09 | $7,513,550.00 | |
| 12/4/2013 | Robert Kluge | SVP | Sell | 12,932 | $80.00 | $1,034,560.00 | |
| 12/2/2013 | Elisha Finney | CFO | Sell | 10,000 | $79.04 | $790,400.00 | |
| 12/2/2013 | Richard Levy | Director | Sell | 20,000 | $79.04 | $1,580,800.00 | |
| 12/2/2013 | Robert Kluge | SVP | Sell | 9,889 | $79.00 | $781,231.00 | |
| 11/29/2013 | Kolleen Kennedy | SVP | Sell | 9,307 | $78.00 | $725,946.00 | |
| 11/25/2013 | Kolleen Kennedy | SVP | Sell | 2,972 | $75.49 | $224,356.28 | |
| 11/22/2013 | Elisha Finney | CFO | Sell | 1,617 | $74.83 | $121,000.11 | |
| 11/14/2013 | Elisha Finney | CFO | Sell | 5,000 | $74.95 | $374,750.00 | |
| 11/1/2013 | Elisha W Finney | CFO | Sell | 5,000 | $72.27 | $361,350.00 | |
| 11/1/2013 | Richard M Levy | Director | Sell | 20,000 | $72.27 | $1,445,400.00 | |
| 10/14/2013 | Robert Kluge | SVP | Sell | 13,889 | $78.00 | $1,083,342.00 | |
| 10/10/2013 | Robert Kluge | SVP | Sell | 13,871 | $77.00 | $1,068,067.00 | |
| 9/20/2013 | Kolleen Kennedy | SVP | Sell | 1,247 | $76.00 | $94,772.00 | |
| 9/16/2013 | Elisha Finney | CFO | Sell | 16,334 | $74.95 | $1,224,233.30 | |
| 9/16/2013 | Kolleen Kennedy | SVP | Sell | 2,562 | $75.00 | $192,150.00 | |
| 9/11/2013 | Elisha W Finney | CFO | Sell | 23,666 | $74.95 | $1,773,766.70 | |
| 9/3/2013 | Elisha Finney | CFO | Sell | 5,000 | $70.95 | $354,750.00 | |
| 9/3/2013 | Richard Levy | Director | Sell | 20,000 | $70.95 | $1,419,000.00 | |
| 8/8/2013 | Kolleen Kennedy | SVP | Sell | 2,400 | $73.50 | $176,400.00 | |
| 8/1/2013 | Elisha W Finney | CFO | Sell | 5,000 | $72.81 | $364,050.00 | |
| 8/1/2013 | R Andrew Eckert | Director | Sell | 1,375 | $72.93 | $100,278.75 | |
| 7/19/2013 | John W Kuo | SVP | Sell | 1,817 | $72.00 | $130,824.00 | |
| 7/17/2013 | Richard M Levy | Director | Sell | 20,000 | $70.00 | $1,400,000.00 | |
| 7/16/2013 | Elisha W Finney | CFO | Sell | 5,000 | $69.95 | $349,750.00 | |
| 6/17/2013 | Elisha W Finney | CFO | Sell | 5,000 | $69.95 | $349,750.00 | |
| 6/17/2013 | Richard M Levy | Director | Sell | 20,000 | $70.00 | $1,400,000.00 | |
| 6/10/2013 | Timothy E Guertin | Director | Sell | 27,000 | $68.81 | $1,857,870.00 | |
| 5/21/2013 | Elisha W Finney | CFO | Sell | 2,313 | $69.86 | $161,586.18 | |
| 5/14/2013 | Elisha W Finney | CFO | Sell | 5,000 | $69.95 | $349,750.00 | |
| 5/14/2013 | John W Kuo | SVP | Sell | 1,112 | $70.00 | $77,840.00 | |
| 5/14/2013 | Richard M Levy | Director | Sell | 20,000 | $70.00 | $1,400,000.00 | |
| 2/14/2013 | John W Kuo | SVP | Sell | 1,111 | $71.05 | $78,936.55 | |
| 9/4/2012 | Kolleen T Kennedy | SVP | Sell | 1,900 | $64.00 | $121,600.00 | |
| 8/20/2012 | Elisha W Finney | CFO | Sell | 4,000 | $59.95 | $239,800.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Varian Medical Systems (NYSE:VAR)
Latest Headlines for Varian Medical Systems (NYSE:VAR)
| Source: |
|
| Date | Headline |
|---|
 | Form 4/A VARIAN MEDICAL SYSTEMS For: Sep 12 Filed by: KENNEDY KOLLEEN T
www.streetinsider.com - September 20 at 10:49 AM |
 | Varian Ranks First in Overall Manufacturer, System, and Service Performance in 2017 Survey of Radiation Oncology Professionals
finance.yahoo.com - September 20 at 10:49 AM |
 | Varian Medical (VAR) Releases FDA-Approved Eclipse 15.5
www.zacks.com - September 19 at 9:15 AM |
| Varian Expands Clinicians' Cancer-fighting Toolkit with Eclipse 15.5
finance.yahoo.com - September 19 at 9:15 AM |
| Varian to Showcase Latest Technologies and Software for Advanced Cancer Care at ASTRO 2017
finance.yahoo.com - September 19 at 9:15 AM |
| Varian Conducts Clinical Workshop, Strengthens Algeria Hold
www.zacks.com - September 18 at 7:45 AM |
 | Notable Friday Option Activity: VAR, GD, DAR - Nasdaq
www.nasdaq.com - September 15 at 3:41 PM |
| Varian Holds First Clinical Workshop at New Algeria Facility
finance.yahoo.com - September 15 at 11:00 AM |
 | Insider Selling: Varian Medical Systems, Inc. (VAR) EVP Sells 933 Shares of Stock
www.americanbankingnews.com - September 14 at 4:32 PM |
| Varian Medical Systems, Inc. (VAR) Expected to Post Earnings of $1.19 Per Share
www.americanbankingnews.com - September 14 at 6:28 AM |
| Form 4 VARIAN MEDICAL SYSTEMS For: Sep 12 Filed by: KENNEDY KOLLEEN T
www.streetinsider.com - September 14 at 1:26 AM |
| CONMED Corporation (CNMD) Ex-Dividend Date Scheduled for September 14, 2017 - Nasdaq
www.nasdaq.com - September 13 at 8:23 PM |
| Varian Medical Systems, Inc. (VAR) EVP Kolleen T. Kennedy Sells 1,088 Shares
www.americanbankingnews.com - September 13 at 4:34 PM |
| Varian Medical Systems, Inc. (VAR) Downgraded by BTIG Research
www.americanbankingnews.com - September 10 at 8:24 AM |
| Dow R. Wilson Sells 15,059 Shares of Varian Medical Systems, Inc. (VAR) Stock
www.americanbankingnews.com - September 8 at 4:22 PM |
 | Benzinga's Top Upgrades, Downgrades For September 7, 2017 - Benzinga
www.benzinga.com - September 7 at 10:45 AM |
| Varian Medical Systems, Inc. (VAR) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - September 6 at 10:58 PM |
| Varian Medical Systems, Inc. (VAR) Rating Reiterated by Royal Bank Of Canada
www.americanbankingnews.com - September 2 at 7:34 AM |
| Contrasting Varian Medical Systems (VAR) & Hologic (HOLX)
www.americanbankingnews.com - September 1 at 10:12 PM |
| Insider Selling: Varian Medical Systems, Inc. (VAR) EVP Sells 931 Shares of Stock
www.americanbankingnews.com - September 1 at 4:20 PM |
| Varian Medical Systems, Inc. (VAR) Rating Reiterated by Robert W. Baird
www.americanbankingnews.com - August 28 at 12:00 PM |
| Varian Medical Systems, Inc. (VAR) Expected to Post Quarterly Sales of $741.71 Million
www.americanbankingnews.com - August 28 at 1:50 AM |
| Zacks: Analysts Anticipate Varian Medical Systems, Inc. (VAR) Will Post Earnings of $1.19 Per Share
www.americanbankingnews.com - August 26 at 8:16 PM |
 | Varian Medical Systems Announces Fiscal Year 2017 Fourth Quarter Earnings Release Date and Upcoming Investor ... - PR Newswire (press release)
www.prnewswire.com - August 26 at 5:24 AM |
| Varian Medical Systems Announces Fiscal Year 2017 Fourth Quarter Earnings Release Date and Upcoming Investor Events
finance.yahoo.com - August 25 at 12:14 PM |
| ETFs with exposure to Varian Medical Systems, Inc. : August 21, 2017
finance.yahoo.com - August 23 at 1:25 PM |
| Varian Medical Systems, Inc. breached its 50 day moving average in a Bullish Manner : VAR-US : August 23, 2017
finance.yahoo.com - August 23 at 1:25 PM |
| Varian Medical Systems’ Recent Stock Performance
finance.yahoo.com - August 17 at 9:00 AM |
| Head-To-Head Contrast: Varian Medical Systems (VAR) versus ABIOMED (ABMD)
www.americanbankingnews.com - August 17 at 4:50 AM |
| Kolleen T. Kennedy Sells 1,088 Shares of Varian Medical Systems, Inc. (VAR) Stock
www.americanbankingnews.com - August 15 at 10:24 PM |
| Varian’s Oncology Business Grows in Emerging Markets
finance.yahoo.com - August 15 at 3:35 PM |
| Varian’s Halcyon Treatment System Sees Emerging Market Demand
finance.yahoo.com - August 15 at 3:35 PM |
| Varian Medical Systems to Hold Investor Meeting at ASTRO in San Diego
finance.yahoo.com - August 15 at 7:59 AM |
| Why Varian Medical Systems’ Profitability Is Improving
finance.yahoo.com - August 15 at 7:59 AM |
| Varian Medical Systems, Inc. (VAR) Rating Increased to Hold at BidaskClub
www.americanbankingnews.com - August 12 at 7:54 AM |
 | Pro-Trader Daily: Corporate News Blog - Bionix(R) Radiation Therapy Signs on Varian Medical Systems as Distributor for its Brachytherapy Applicators
www.finanznachrichten.de - August 11 at 8:47 PM |
| See what the IHS Markit Score report has to say about Varian Medical Systems Inc.
finance.yahoo.com - August 11 at 3:43 PM |
| Varian Announces New VP of Investor Relations - PR Newswire (press release)
www.prnewswire.com - August 10 at 8:35 PM |
| Varian Medical (VAR) Signs Distribution Deal with Bionix - Nasdaq
www.nasdaq.com - August 10 at 8:35 PM |
| Varian Medical (VAR) Signs Distribution Deal with Bionix
finance.yahoo.com - August 10 at 3:31 PM |
| Varian Medical Systems, Inc. :VAR-US: Earnings Analysis: Q3, 2017 By the Numbers : August 10, 2017
finance.yahoo.com - August 10 at 3:31 PM |
| Zacks: Analysts Expect Varian Medical Systems, Inc. (VAR) Will Announce Quarterly Sales of $741.71 Million
www.americanbankingnews.com - August 10 at 2:38 PM |
| Varian Announces New VP of Investor Relations
finance.yahoo.com - August 10 at 9:20 AM |
| First Patient Treated with Varian HyperArc High Definition Radiotherapy
finance.yahoo.com - August 9 at 8:50 AM |
| Varian Medical Systems Signs Brachytherapy Applicator Distribution Agreement with Bionix Radiation Therapy
finance.yahoo.com - August 9 at 8:49 AM |
| Dow R. Wilson Sells 15,059 Shares of Varian Medical Systems, Inc. (NYSE:VAR) Stock
www.americanbankingnews.com - August 8 at 10:28 PM |
| Varian Medical Systems, Inc. (NYSE:VAR) Expected to Announce Earnings of $1.19 Per Share
www.americanbankingnews.com - August 8 at 10:22 AM |
| Earnings Review and Free Research Report: Varian Medical Systems Reported Better than Expected Earnings
finance.yahoo.com - August 7 at 8:03 AM |
| Varian Medical Systems, Inc. (VAR) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - August 3 at 1:12 PM |
 | BRIEF-Varian Medical received orders to provide suites of software for national proton therapy centers in UK
www.reuters.com - August 3 at 8:30 AM |
Varian Medical Systems (VAR) Chart for Wednesday, September, 20, 2017
